Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars
Phase 4
- Conditions
- PulpitisDental Pulp DiseaseTooth Diseases
- Interventions
- Drug: FormocresolDrug: Mineral Trioxide Aggregate
- Registration Number
- NCT02286648
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
The purpose of this study is to evaluate the clinical and radiographic success rate of Miniature pulpotomy with Mineral Trioxide Aggregate (MTA) in primary molars.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
-
healthy people(without any systemic disease)
-
teeth :
- no clinical or radiographic evidence of pulp degeneration
- the possibility of proper restoration of the teeth
Read More
Exclusion Criteria
-
teeth :
- excessive bleeding from the exposure site
- internal root resorption
- interradicular and/or periapical bone destruction
- swelling or sinus tract
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Formocresol Formocresol pulpotomy with FC Mineral Trioxide Aggregate Mineral Trioxide Aggregate pulpotomy with MTA
- Primary Outcome Measures
Name Time Method successful outcome of treatment as indicated by clinical signs defined with observation and check list up to 12 months success or failure of treatment defined with observation and check list
- Secondary Outcome Measures
Name Time Method successful outcome of treatment as indicated by radiographic signs defined with observation and check list up to 12 months success or failure of treatment defined with observation and check list
Trial Locations
- Locations (1)
Mashhad University of Medical Siences
🇮🇷Mashhad, Khorasan Razavi, Iran, Islamic Republic of